Callan Capital, LLC

SEC CIK: 0001542166
Latest filing: Apr 29, 2025

SEC filings (opens in a new tab)

EVFM holding history

Evofem Biosciences, Inc. in every 13F filed by Callan Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EVFM overview All 13F holders of EVFM Full Q1 2025 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of EVFM by Callan Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−50,000−100.0%	Sold out	Holders
Q3 2021	50,000	$37.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2021	50,000	$57.0K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	50,000	$88.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.